Neuroplasticity is disrupted in depression.3 In response, the brain attempts to restore neuroplasticity by increasing the S100B levels in depressive patients.19 However, the compensatory mechanism varies among depressive patients.19 As a result, some depressive patients have high concentrations of S100B, while others have low concentrations. Here, S100B is linked to depressive disorder.